Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
5
×
deals
5
×
detroit blog main
detroit top stories
eli lilly
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
pfizer
5
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
5
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer immunotherapy
investing
takeda pharmaceutical
alzheimer's disease
fda
merck
moderna
novartis
What
bio
roundup
drug
buy
companies
growing
pharmaceutical
typically
acquisitions
alliance
alzheimer’s
approved
bails
biggest
brand
bridgebio
bristol
build
calls
capital
car
ceo
changing
color
company’s
crispr
daniel
days
debut
develop
different
digital
disease
drugs
dyne’s
emerges
epidemic
fail
fatty
fda
Language
unset
Current search:
cancer
×
startups
×
deals
×
pfizer
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More